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Schistosoma haematobium: An old neglected disease—No more?
Schistosomiasis is a trematode infection that is still spreading through Africa [1,2,3]. It is
responsible for urogenital (S. haematobium [SH]) and intestinal/hepatic (S. mansoni and other
species) complaints and chronic morbidity [4]. Currently, more than 700 million people live
in endemic areas [3]. The World Health Organization’s strategic plan for 2012–2020 for schis-
tosomiasis is aimed at controlling morbidity by 2020, eliminating SH infection as a public
health problem, and interrupting transmission in select areas by 2025 [5]. These plans are,
however, in peril, owing to changes in the epidemiology of SH infection over the last two
years. First, campaigns aimed at controlling schistosomiasis through mass drug administration
(MDA) have recently been shown to fail at reaching the target population. In 2012, a coverage
rate of only 16% of patients needing treatment for schistosomiasis was reported [6]; lack of
coverage was reported in 44% of the study population in 2016 [7]. Health education programs
and water snail (intermediate host) eradication campaigns, although proven to be effective in
reducing the risk of new infections from the 1960s to the 1980s, are no longer actively pursued
[5]. Second, the recent rise in the northbound migratory flux from Africa through the Mediter-
ranean basin is steadily contributing to an expansion of the areas where schistosomiasis may
be diagnosed. Indeed, within the current migratory flux to Italy and other Mediterranean
countries, the most representative nations of origin (The Gambia, Mali, Nigeria, and Sudan)
are countries with high endemicity of urogenital schistosomiasis [8,9,10].
S. haematobium presentation at the emergency department and
increasing referral to urology and radiology—Urine test no more?
This expansion of urogenital schistosomiasis may lead to a lack of recognition of the symptoms
of the disease in countries with a high inflow of migrants and where schistosomiasis is only
rarely encountered [11]. In nonendemic northern Mediterranean and European countries,
which are targets of the migratory flux, the symptoms of urogenital schistosomiasis (e.g.,
hematuria, urinary frequency, burning micturition, and suprapubic discomfort) may be
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misinterpreted by the first physician that examines the patient in the emergency department
(ED). ED physicians may prescribe a workup that is generally prescribed for European
patients, in whom such symptoms primarily suggest complicated cystitis/pyelonephritis or a
urinary tract neoplasm. Hence, chronic schistosomiasis occurring in young adult migrants
may initially be misdiagnosed or, rather, recognized with delay. Parasitological methods to
detect SH eggs in urine and reagent strips to detect microhematuria are very helpful diagnostic
tools in endemic areas, but they unfortunately lack the sensitivity to detect mild infections
[12]. Moreover, these methods are heavily operator-dependent and involve observer-depen-
dent personal skills. The introduction of recently described highly sensitive and specific diag-
nostic tests in clinical practice will be needed to improve diagnostic precision in controversial
cases [13]. Thus, in developed countries, the combination of the increasing migratory flux
from endemic areas and the failing coverage of preventive MDA programs in Africa [7] may
result in patients presenting with symptomatic urogenital schistosomiasis to medical depart-
ments or surgical wards in which this condition is not immediately recognized. The presenta-
tion/referral of a series of consecutive patients who came to the ED of our university teaching
hospital in Genoa (northern Italy) confirms this clinical pattern.
We reviewed the clinical history, laboratory findings, and imaging findings in a series of
eight male patients (migrants from West Africa) who were consecutively encountered in our
practice from July 2015 to January 2016. Patients were first seen by an ED physician and then
referred to different wards or services according to their symptoms. The decision based on the
clinical workup of each patient was taken by different ED physicians according to their clinical
judgment and the availability of services, rather than shared protocols. The present review pro-
cess was aimed at understanding how the different specialists approached each case, how the
diagnosis was surmised, how the diagnosis was finally confirmed, and whether improvements
in the system could be introduced. All patients were accompanied to the ED by a representa-
tive of the non-governmental organization (NGO) that had them in their charge.
All eight patients presented with hematuria. The ED physicians decided to refer five of
them to the radiologist, one to the urologist, and three to the infectious disease specialist
(Table 1). In one case, both the radiologist and infectious disease specialist were simulta-
neously summoned by the emergency physician. The first approach of both radiologists and
urologists was the evaluation of the lower urinary tract (with ultrasonography [US] and cystos-
copy, respectively).
Seven patients had bladder abnormalities that were considered compatible with chronic SH
infection [14] (Table 2). US showed focal thickening of the bladder wall and small parietal veg-
etations in four patients, with wall calcifications in one of these patients. Unenhanced com-
puted tomography (CT) was performed in two cases: focal calcification on the posterior wall of
the bladder was seen in one case, and diffuse calcification (involving the whole wall) was seen
Table 1. Demographic patient data and clinical presentation of patients with Schistosoma haematobium infection.
Patient Nationality Age, Years Clinical Presentation Specialist Who First Encountered the Patient
1 Mali 21 Hematuria Radiologist
2 The Gambia 27 Hematuria Infectious disease specialist
3 Guinea Bissau 25 Hematuria Radiologist
4 Benin 20 Hematuria Radiologist
5 Mali 30 Hematuria Urologist
6 Mali 22 Hematuria Radiologist
7 Italy 50 Microhematuria Radiologist & infectious disease specialist
8 Ivory Coast 30 Hematuria Infectious disease specialist
doi:10.1371/journal.pntd.0005237.t001
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in the other. Thin, linear calcifications within the bladder wall are a “classical” finding, suggest-
ing urinary SH infection. This patient was the first one encountered by the radiologist, who
therefore called attention to the presence of this disease in the subsequent patients, who had
less specific imaging findings [15].
All eight patients with macroscopic hematuria underwent cystoscopic examination, as a
first approach in one case and to exclude the presence of a tumor in the others. Cystoscopic
findings were compatible with intermediate and late manifestations of SH infection (Fig 1).
Although SH infection may lead to squamous cell carcinoma of the bladder, this was not
detected in this small series, which is in line with the reported low incidence of this
Table 2. Laboratory, imaging, cystoscopic, and pathological findings of the eight patients presenting with Schistosoma haematobium infection.
Patient Laboratory Imaging Cystoscopy Histology
1 Anti-schistosoma
Ab +
Two vegetations on the bladder wall, left
hydroureteronephrosis on US, and diffuse linear
calcification of the bladder wall on CT
Two broad-based mamillated lesions
in the posterior bladder wall
Proliferative and granulomatous cystitis with
erosive and polypoid aspects; partly calcified
eggs and adult parasites
2 Anti-schistosoma
Ab +
Negative Negative Not performed
3 Anti-schistosoma
Ab +
Irregular bladder wall with three micronodular lesions
and fine hyperechoic lines in the bladder wall on US
Lesions of the posterior bladder wall Intense micropolypoid cystitis with rare calcified
schistosome eggs
4 Not performed Focal thickening and nodular lesions of the bladder
wall on US; fine calcifications on CT
Hyperemic nodular areas with edema
that bled easily involving the
posterolateral bladder wall
Intense eosinophilic cystitis with partially
calcified schistosome eggs
5 Anti-schistosoma
Ab +
Not performed Small hyperemic area in the posterior
bladder wall with no evidence of active
lesions; no biopsy
Not performed
6 Anti-schistosoma
Ab +
Irregular bladder wall with one nodular lesion on US Lesion of the posterior bladder wall Intense eosinophilic acute cystitis, focally
proliferative and microcystic, with numerous,
rarely calcified, schistosome eggs
7 Anti-schistosoma
Ab +
Negative Not performed Not performed
8 Anti-schistosoma
Ab +
Negative Negative; no biopsy Not performed
Ab, antibody; US, ultrasonography; CT, computed tomography
doi:10.1371/journal.pntd.0005237.t002
Fig 1. Representative ultrasonographic, cystoscopic, and pathological findings in a patient with
chronic schistosomiasis presenting to the ED. (A) Ultrasonograph of the bladder shows a vegetation
associated with bladder wall thickening; fine and diffuse calcifications are also visible. (B) Cystoscopic image
obtained after transurethral resection shows an adult S. haematobium worm. (C) An area of marked, diffuse,
acute inflammation with numerous eosinophils surrounds some calcified S. haematobium eggs; the parasite is
also identified.
doi:10.1371/journal.pntd.0005237.g001
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complication (3–4/100,000) [16]. SH infection was confirmed pathologically in the five cases
in which a biopsy specimen was obtained.
No bladder biopsy was performed in three cases that met the composite clinical and diag-
nostic criteria for SH infection (Table 2). In similar cases, as discussed above, availability of a
more sensitive diagnostic technique for urinary SH antigen detection will provide useful infor-
mation [12,13]. All patients were treated with praziquantel (40 mg/kg as a single dose).
Thus, our experience with the series described suggests that, in developed areas, young
migrants from SH-endemic countries may predominantly have hematuria and may present to
—or rather, may be accompanied by NGO representatives to—the ED; further, other differen-
tial diagnoses may primarily be considered, should anamnestic parameters (age and country of
origin) not be adequately considered. Within this framework, there was an excess use of
resources (US, CT, and emergency cystoscopy), both because SH infection was not considered
in the first place and, more importantly, because a diagnostic workup commonly used for
young European patients presenting with hematuria was employed.
Schistosoma haematobium: Tropical—No more?
The number of international migrants worldwide has continued to grow rapidly over the past
15 years. Over the last year, this number has increased sharply, and the current migration pat-
terns are likely to persist in the near future [17–18]. In view of the high migratory flux to Euro-
pean countries, this pattern of the clinical presentation of SH infection may more frequently
be observed, resulting in an increased number of admissions to the ED and the need for
greater awareness of this condition.
The recently described Corsica outbreak of SH infection in 2013 and the subsequent trans-
mission occurring in 2015 after a bathing ban had been lifted [19–20] provided evidence that
local transmission continues to occur. Autochthonous transmission is possible in parts of
southern Europe where the intermediate host species, Bulinus truncatus, has been found [20–
22]. This species has been identified in foci in Spain, Portugal, Sicily, and Greece. The fact that
permissive species are reported in these areas (and that, in at least two of these areas, Sicily and
Greece, a considerable number of migrants are concentrated upon arrival) could open the
door to additional areas serving as regions where the transmission cycle is maintained locally.
This possibility should raise concerns about the possible maintenance of the SH transmission
cycle in Europe and provide a sense of urgency in addressing it. Interestingly, in line with this
possibility, the SH isolates detected in the cases recorded in Corsica have been traced to a West
African (Senegal) origin mixed with local animal schistosomes, based on molecular analyses
[19]. These observations, therefore, suggest that SH infection in Europe should not be regarded
as an issue affecting only immigrants or one that is devoid of potential concern for the native
population in future. Indeed, the presence of intermediate snail hosts, together with the
increasing flux from endemic areas, could potentially transfer SH endemicity to some areas in
southern Europe. In this context, a scenario with increased inappropriate use of health services
and underestimated and hidden costs, as described above, may represent an unacceptable
additional burden of disease.
Interventions and policy changes—Neglect no more?
Abandoning the present shortsighted or passive attitude in European countries regarding SH
infection in migrant populations and the associated potential risks for both migrant and local
populations may be difficult owing to the current limited awareness. The present case series
highlights the fact that this disease is not considered a diagnostic possibility in European EDs,
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and this may lead to a misuse of health resources. Awareness could induce renewed efforts
towards a more cost-effective approach.
Useful measures to constructively address this issue include educational, epidemiological,
and clinical interventions. First, educational efforts have to target emergency and primary care
physicians. Population changes need to be considered with increased awareness of SH infec-
tion symptoms and upgrading of diagnostic workup protocols to include not only symptoms
but also disease prevalence in the country of origin. Increased involvement of infectious/tropi-
cal disease specialists, as well as widespread use of urine testing as a first diagnostic approach,
will improve both the care of these populations and cost effectiveness. Second, a registry of
emergency referrals to the ED of young adults from endemic countries would provide a real
measure of the problem of SH infection in Europe. Distribution of urine tests to NGO facilities
and testing of migrants on arrival would increase the accuracy of the estimation of the real
prevalence of SH infection in this population. Further, a systematic survey of areas with the
presence of suitable intermediate snail hosts could dismiss or confirm the risk for the transi-
tion to a local SH transmission cycle. In addition, geolocalization of SH infection cases in
migrant populations may allow for assessment of the coexistence of SH-infected persons in
areas where the intermediate snail host is known to be distributed, thus allowing for the esti-
mation of the risk for local SH endemic transmission.
Finally, the introduction of MDA upon arrival in Europe in specific target populations may
represent an innovative and cost-effective solution to decrease the long-term clinical complica-
tions of urogenital schistosomiasis and to reduce urinary egg elimination, thus helping to
avoid a future persistence of SH infection in Europe. Identification of the optimal target popu-
lation and reaching the identified target population should not be an issue among arriving
migrants, thus allowing for campaign efficacy with high coverage rates [10–20].
In conclusion, SH infection is potentially set to become a stable presence in Europe, with a
high likelihood of new prevalent cases associated with migration and the risk of a rising inci-
dence, should establishment of endemicity occur in freshwater areas where intermediate snail
hosts are already present. To improve the current efficiency of care, more attention should be
paid to identification procedures and clinical protocols.
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